Helium (He) is typically used as a coolant for the superconducting magnets in MRI machines because of its extremely low boiling point (around -269°C or -452.2°F). However, it is a non-renewable resource, and its scarcity leads to increased costs and supply chain vulnerabilities. Additionally, #helium management in #mri machines involves complex infrastructure and maintenance. Philips BlueSeal magnet is industry-leading solution to Helium-Free MRI Technology and represents a significant advancement in medical imaging. It eliminates the dependence on helium, reducing operational costs and the need for frequent refills of liquid helium. This solution has a notable impact on Environmental, Social, and Governance (ESG) criteria, particularly in the environmental domain. It offers a more sustainable and cost-effective alternative to traditional systems, decreases carbon footprint in usage and associated logistical transportation. The alleviated dependency on helium and reduced cost make MRI more accessible worldwide, which can enhance safety and diagnostic capabilities in underserved regions, contributing to better health outcomes and equity. Moreover, helium-free systems help healthcare facilities comply with stringent environmental regulations, align with corporate sustainability goals and reporting requirements, demonstrating commitment to sustainable practices and building stakeholder trust. With BlueSeal becoming more prevalent, we are shifting to a helium-free MRI world, and creating significant positive impact in the society and in the future. Find more on Philips #BlueSeal -> https://lnkd.in/exVVthsd Atul Gupta, MD https://lnkd.in/etqduuv5 #Philips #innovation #ESG

January is National Glaucoma Awareness Month. Glaucoma is a group of eye conditions that damage the optic nerve, which is crucial for transmitting visual information from the eye to the brain. One of ExSight Venture's portfolio companies, Elios Vision, is making advancements to combat this condition.  At OIS XIII Dr. Sahar Bedi, a glaucoma specialist, discussed Elios's technology for treating glaucoma. The technology involves a laser system that creates implant-free microchannels along the trabecular meshwork to improve aqueous flow and reduce intraocular pressure (IOP). The laser technology aims to preserve the function of the trabecular meshwork while achieving sustained IOP reduction. Dr. Bedi described the procedure, showcasing its simplicity and adaptability for both glaucoma and cataract surgeons. She presented clinical data from about 20 studies involving 2,300 eyes, showing IOP reduction ranging from 29% to 43% and medication reduction from 47% to 61%. The technology is undergoing FDA pivotal trials for both combination and standalone procedures, with an estimated launch in early 2025.  Watch the full video below. #glaucomaawareness #glaucomaawarenessmonth #investintheeye #ophthalmology

#Neuroscience and #biomedical #engineering #startup BrainBridge exits stealth with ambitious goal to develop 'world's first head transplant system'. The system integrates advanced #robotics and #Al to execute complete head and face transplantation procedures.

Don't miss today's RSS webinar on SRS Thalamotomy for Treatment of Essential Tremor💡 Sign up to listen to Dr. Balousek, Sophia Loiselle and Dr. Loiselle on how to identify patients for radiosurgical thalamotomy, understand stereotactic localization referencing anterior and posterior commissures and potential benefits of computer aided target identification. #SRS #GammaKnife #RSS #thalamotomy

SURGERIX team presented by Gaukhar Mukash and Paavo Vartiainen at Neurokirurgien opintopäivät 2024 today and tomorrow. Strengthening our network in the Finnish Neurosurgical scene, already including Microsurgery Center and @prof Ville Leinonen from Pohjois-Savon hyvinvointialue. We are stepping to the stage of collecting neurosurgeon feedback after a hands-on trial of two solutions: Instrument transparency and context-preserving magnification. 🧠🔬

In the area of ophthalmology, the Hôpital Fondation Adolphe de Rothschild is using advanced real-time Doppler holography, an imaging technique that combines our Phantom cameras with computational image rendering software. Check out the post below to learn more about how this technique promises to revolutionize eye angiography, leading to more efficient and repeatable patient screenings: https://ow.ly/BpxN50T1s36 #imaging #highspeed #Phantomhighspeed #medical #opthalmology

Honored to have been invited to speak at the Cold Spring Harbor Laboratory Symposium on brain-body physiology and to be able to provide my perspective on this field in this interview. Here, I discuss my deep fascination with studying how #nutrients impact #brain function and #physiology. Understanding these processes helps us uncover the mechanisms that guide complex decisions and overall physiology. I emphasize the incredible potential of #Drosophila as a model system, enabling us to dissect these mechanisms in the context of a whole animal. I also highlight the importance of collaborations and interdisciplinarity in our research. Working together with brilliant minds drives innovation and discovery, pushing the boundaries of what we can achieve in this field. I'm excited about the future of this interdisciplinary field and the new insights we're uncovering every day. Watch the full interview here: https://lnkd.in/d7CW9xqe #Neuroscience #Drosophila #BrainBodyConnection #ScientificResearch #Collaboration #Innovation

ViaLase Secures $40 Million in Series C Funding to Advance Novel Glaucoma Treatment Excited to announce that ViaLase, Inc has closed a $40 million Series C funding round! This funding will fuel the commercialization of our groundbreaking ViaLase® Laser, a potential first-in-class femtosecond laser for treating primary open-angle glaucoma. The ViaLase Laser utilizes a minimally invasive procedure called FLigHT (femtosecond laser image-guided high-precision trabeculotomy) to create channels in the trabecular meshwork, reducing intraocular pressure. This technology has the potential to revolutionize glaucoma treatment by offering ophthalmologists greater precision and visibility. https://lnkd.in/dHxySXvF #glaucoma #femtosecondlaser #ophthalmology #funding #medicaltechnology #FLigHT #visioncare #PhotonicSpots #PhotonicsTimes Photonics Spectra

EVO ICL = gamechanger! Patients think of the terms "refractive surgery" and "LASIK" being synonymous. Often the belief is if they're not candidates for LASIK, they aren't candidates for refractive surgery. Not true! Not even close! With #EVO, we see patients actually IMPROVE VA compared to their glasses or contact lenses preop. How? Location, location, location! It's all about correction at the nodal point! STAAR Surgical Summit Eye Care #EvoICL https://lnkd.in/gfqHfZja

Meet another member of our panel discussion: Dr. Loes van Dam! Dr. van Dam group works with multisensory percepton and integration, which are key elements for the "Integration of Neuroprosthetics into our Daily Lives". Join us in this exciting discussion on #Neurizons2024 ! @unigoettingen @unimedizin_goettingen #Neurizons #paneldiscussion #MaxPlanck #maxplanckinstitute #maxplanckgesellschaft #IMPRS #neuroprosthetics #goettingen